Zinc Porphyrin Tweezer for Determining Absolute Configurations
216±224
TFA to yield the conjugate 20 (36 mg, 70%) according to the general
procedures for conjugate synthesis. 1H NMR (CD3OD, 300 MHz): d 0.99
(s, 3H; CH3), 1.01 (s, 3H; CH3), 2.20 ± 2.38 (m, 1H; CH(CH3)2), 3.76 (s, 3H;
CO2CH3), 4.28 (s, 2H; CH2NH2TFA), 4.53 ± 4.62 (m, 1H; CHCH(CH3)2),
7.65 (dd, J 1.72, 4.99 Hz, 1H), 8.18 (d, J 1.72 Hz, 1H), 8.73 (d, J
4.96 Hz, 1H).
Acknowledgment
The studies were supported by NIH grant GM 34509.
[1] N. Harada, K. Nakanishi, Circular Dichroic Spectroscopy - Exciton
Coupling in Organic Stereochemistry, University Science Books, Mill
Valley, 1983, p. 350.
[2] K. Nakanishi, N. Berova in Circular Dichroism, Principles and
Applications, (Eds.: K. Nakanishi, N. Berova, R. W. Woody), VCH
Publishers, New York, 1994, pp. 361 ± 398.
[3] D. Rele, N. Zhao, K. Nakanishi, N. Berova, Tetrahedron 1996, 52,
2759 ± 2776.
[4] M. Ojika, H. V. Meyers, M. Chang, K. Nakanishi, J. Am. Chem. Soc.
1989, 111, 8944 ± 8946.
Carrier 3/(S)-a-amino-g-butyrolactone conjugate 21: (S)-a-Amino-g-bu-
tyrolactone hydrobromide (18 mg, 96 mmol) was treated with carrier 1a and
then with TFA to yield the conjugate 21 (38 mg, 86%) according to the
general procedures for conjugate synthesis. 1H NMR (CD3OD, 400 MHz):
d 2.42 ± 2.53 (m, 1H; CHCH2), 2.58 ± 2.65 (m, 1H; CHCH2), 4.27 (s, 2H;
CH2NH2TFA), 4.32 ± 4.38 (m, 1H; CHOCO), 4.45 ± 4.53 (m, 1H;
CHOCO), 4.85 (dd, J 9.31, 11.01 Hz, 1H; NHCHCOO), 7.62 (d, J
4.90 Hz, 1H), 8.16 (s, 1H), 8.71 (d, J 4.94 Hz, 1H); MS (ESI): m/z:
[MH] 236.1.
Carrier 3/l-a-amino-e-caprolactam conjugate 22: l-a-Amino-e-caprolac-
tam (13 mg, 94 mmol) was treated with carrier 1a and then with TFA to
yield the conjugate 22 (36 mg, 75%) according to the general procedures
for conjugate synthesis. 1H NMR (CD3OD, 400 MHz): d 1.34 ± 1.45 (m,
1H; CH), 1.55 ± 1.65 (m, 1H; CH), 1.82 ± 1.94 (m, 2H; 2CH), 1.96 ± 2.13 (m,
2H; 2CH), 3.25 ± 3.40 (d, J 9.80 Hz, 1H; NHCHCO), 4.27 (s, 2H;
CH2NH2TFA), 7.65 (d, J 4.85 Hz, 1H), 8.18 (s, 1H), 8.69 (d, J 4.86 Hz,
[5] W. T. Wiesler, N. Berova, M. Ojika, H. V. Meyers, M. Chang, P. Zhou,
L. C. Lo, M. Niwa, R. Takeda, K. Nakanishi, Helv. Chim. Acta. 1990,
73, 509 ± 551.
[6] M. Chang, H. V. Meyers, K. Nakanishi, M. Ojika, J. H. Park, M. H.
Park, R. Takeda, J. T. Vazquez, W. T. Wiesler, Pure Appl. Chem. 1989,
61, 1193 ± 1200.
[7] N. Zhao, K. Narendra, K. Neuenschwander, K. Nakanishi, N. Berova,
J. Am. Chem. Soc. 1995, 117, 7844 ± 7845.
[8] N. Zhao, N. Berova, K. Nakanishi, M. Rohmer, P. Mougenot, U. J.
Jurgens, Tetrahedron 1996, 52, 2777 ± 2788.
1H); MS (ESI): m/z: [MH] 263.2; HR-FABMS of C13H19O2N4: m/z:
[M1] calcd. 263.1508, found 263.1508.
Carrier 3/(S)-1-methoxy 2-propylamine conjugate 23: (S)-1-Methoxy
2-propylamine (4.5 mg, 51 mmol) was treated with carrier 1a and then
with TFA to yield the conjugate 23 (16 mg, 72%) according to the general
procedures for conjugate synthesis. 1H NMR (CD3OD, 300 MHz): d 1.27
(d, J 6.78 Hz, 3H; CH3), 3.38 (s, 3H; OCH3), 3.42 ± 3.53 (m, 2H;
CH2OCH3), 4.27 (s, 2H; CH2NH2TFA), 4.24 ± 4.35 (m, 1H; NHCH), 7.58
(d, J 4.93 Hz, 1H), 8.17 (s, 1H), 8.69 (d, J 4.93 Hz, 1H).
[9] B. H. Rickman, S. Matile, K. Nakanishi, N. Berova, Tetrahedron 1998,
54, 5041 ± 5064.
[10] O. Gimple, P. Schreier, H.-U. Humpf, Tetrahedron: Asymmetry 1997, 8,
11 ± 14.
[11] O. Gimple, P. Schreier, H.-U. Humpf, J. Org. Chem. 1998, 63, 322 ±
325.
[12] X. Huang, B. H. Rickman, B. Borhan, N. Berova, K. Nakanishi, J. Am.
Chem. Soc. 1998, 120, 6185 ± 6186.
[13] H. E. Smith, J. R. Neergaard, J. Am. Chem. Soc. 1997, 119, 116 ± 124.
[14] H. E. Smith in Circular Dichroism. Principles and Applications, (Eds.:
K. Nakanishi, N. Berova, R. W. Woody), VCH Publishers, New York,
1994, pp. 413 ± 442.
[15] S. Takenaka, M. Koden, J. Chem. Soc. Chem. Commun. 1978, 830.
[16] S. Takenaka, M. Ako, T. Kotani, A. Matsubara, N. Tokura, J. Chem.
Soc. Perkin Trans. 2 1978, 95 ± 99.
[17] S. Takenaka, K. Kondo, N. Todura, J. Chem. Soc. Perkin Trans. 2 1975,
1520 ± 1524.
[18] S. Takenaka, Y. Miyauchi, N. Tokura, Tetrahedron Lett. 1976, 42,
3811 ± 3814.
Carrier 3/tetraacetyl d-glucosamine conjugate 24: Tetraacetyl d-glucos-
amine hydrochloride (10 mg, 21 mmol) was treated with carrier 1a and then
with TFA to yield the conjugate 24 (12 mg, 71%) according to the general
procedures for conjugate synthesis. 1H NMR (CD3OD, 400 MHz): d 1.91,
2.05, 2.09, 2.19 (4s, 12H; 4CH3), 4.05 ± 4.12 (m, 1H; CH), 4.17 ± 4.25 (m,
1H; CH), 4.27 (s, 2H; CH2NH2TFA), 4.53 ± 4.62 (m, 1H; CH), 5.18 ± 5.28
(m, 1H; CH), 5.42 ± 5.55 (m, 1H; CH), 6.04 (d, J 8.77 Hz, 0.25H, b
anomeric proton), 6.22 (d, J 3.63 Hz, 0.75H, a anomeric proton), 7.62 (d,
J 4.95 Hz, 1H), 8.14 (s, 1H), 8.69 (d, J 4.90 Hz, 1H); MS (ESI): m/z:
[MH] 482.2; HR-FABMS of C21H27O10N3K: m/z: [MK] calcd.
520.1334, found 520.1340.
Carrier 3/5-androsten-17b-amino-3b-ol conjugate 25: 5-Androsten-17b-
amino-3b-ol (15 mg, 52 mmol) was treated with carrier 1a and then with
TFA to yield the conjugate 25 (32 mg, 95%) according to the general
procedures for conjugate synthesis. 1H NMR (CD3OD, 400 MHz): d 0.82,
1.02 (2s, 6H; 2CH3), 1.08 ± 1.88, 1.92 ± 2.05, 2.11 ± 2.30 (m, 20H), 3.48 ± 3.58
(m, 1H; CHOH), 4.02 ± 4.12 (m, 1H; CHNH), 4.28 (s, 2H; CH2NH2TFA),
5.38 (d, J 5.15 Hz, 1H; CH), 7.38 (d, J 4.95 Hz, 1H), 8.09 (s, 1H), 8.52
(d, J 4.90 Hz, 1H).
[19] E. Yashima, T. Matsushima, Y. Okamoto, J. Am. Chem. Soc. 1995, 117,
11596 ± 11597.
[20] E. Yashima, T. Matsushima, Y. Okamoto, J. Am. Chem. Soc. 1997, 119,
6345 ± 6359.
[21] S. Matile, N. Berova, K. Nakanishi, J. Fleischhauer, R. Woody, J. Am.
Chem. Soc. 1996, 118, 5198 ± 5206.
[22] 4-N-Boc-aminomethyl 2-carboxylic acid (1a) and porphyrin tweezer 4
will be made commercially available by TCI America.
[23] W. K. Fife, J. Org. Chem. 1983, 48, 1375 ± 1377.
[24] J.-A. Fehrentz, B. Castro, Synthesis 1983, 676 ± 678.
[25] Mirror image CD spectrum was obtained when the enantiomer of 10
was measured with porphyrin tweezer 4.
[26] C. R. Cantor, P. R. Schimmel in Biophysical Chemistry, Vol. 3, W. H.
Freeman and Company, San Francisco, 1980, pp. 1135 ± 1138.
[27] M. Kasha, Radiat. Res. 1963, 20, 1059 ± 1071.
[28] M. Kasha, H. R. Rawls, M. A. El-Bayoumi, Pure Appl. Chem. 1965,
11, 371 ± 392.
[29] C. A. Hunter, J. K. M. Sanders, A. J. Stone, J. Chem. Phys. 1989, 133,
395 ± 404.
[30] X. Huang, B. Borhan, N. Berova, K. Nakanishi, J. Ind. Chem. Soc.
1998, 75, 725 ± 728.
[31] With monoamines such as (S)-cyclohexylethylamine, formation of the
1:1 host ± guest macrocyclic complex is not possible. No isosbestic
point was observed during addition of the monoamine to porphyrin
tweezer 4, while the UV/Vis maxima of the monoamine/porphyrin
tweezer 4 complex shifted continuously from 416 nm (empty host) to
428 nm (saturated host).
Carrier 3/methyl l-acosamine conjugate 26: Methyl l-acosaminide hydro-
chloride (9 mg, 45 mmol) was treated with carrier 1a and then with TFA to
yield the conjugate 26 (20 mg, 93%) according to the general procedures
for conjugate synthesis. 1H NMR (CD3OD, 500 MHz): d 1.28 (d, J
4.85 Hz, 3H; CH3), 1.82 ± 1.88 (m, 1H; CH), 2.06 ± 2.14 (m, 1H; CH),
3.18 ± 3.25 (m, 1H; CH), 3.35 (s, 3H; OCH3), 3.66 ± 3.74 (m, 1H; CH), 4.25
(s, 2H; CH2NH2TFA), 4.31 ± 4.38 (m, 1H; CH), 4.71 (d, J 2.95 Hz, 1H;
OCHOCH3), 7.58 (d, J 4.95 Hz, 1H), 8.14 (s, 1H), 8.69 (d, J 5.01 Hz,
1H); MS (ESI): m/z: [MH] 296.2.
Carrier 3/l-threo-sphingosine conjugate 27: l-threo-Sphingosine (2 mg,
6.7 mmol) was treated with carrier 1a and then with TFA to yield the
conjugate 27 (3.7 mg, 83%) according to the general procedures for
conjugate synthesis. 1H NMR (CD3OD, 500 MHz): d 0.89 (t, J 6.86 Hz,
3H; CH3), 1.19 ± 1.40 (m, 22H), 1.95 ± 2.05 (m, 2H; CH), 3.65 ± 3.72, 3.74 ±
3.80 (m, 2H, CH2OH), 4.02 ± 4.12 (m, 1H; NHCHCH2OH), 4.25 (s, 2H;
CH2NH2TFA), 4.38 ± 4.42 (m, 1H; NHCHCHOH), 5.48 ± 5.52 (m, 1H;
CHCHCH2), 5.70 ± 5.79 (m, 1H; CHCHCH2), 7.58 (d, J 4.95 Hz, 1H),
8.14 (s, 1H), 8.68 (d, J 4.96 Hz, 1H).
Chem. Eur. J. 2000, 6, No. 2
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000
0947-6539/00/0602-0223 $ 17.50+.50/0
223